PDF(Pubmed)
Abstract：
The investigation of therapeutic cancer vaccines has been ongoing for the past century. Herein, we used VOSviewer and CiteSpace to perform the first global bibliometric analysis of the literature on therapeutic cancer vaccines from 2013 to 2022 aiming to explore the current status and potential research trends. The findings revealed a consistent upward trend in both publication counts and citations. The United States emerged as the leading contributor with the highest number of published papers. Additionally, the analysis of references and keywords indicated that therapeutic cancer vaccines have long been popular topics, whereas neoantigen vaccines, mRNA vaccines, combination strategies, and vaccine delivery systems are emerging research hotspots. This bibliometric study provides a comprehensive and important overview of the current knowledge and potential developments in therapeutic cancer vaccines from 2013 to 2022, which may serve as a valuable reference for scholars interested in further exploring this promising field.
摘要：
治疗性癌症疫苗的研究在过去的一个世纪中一直在进行。在这里，我们使用VOSviewer和CiteSpace对2013年至2022年有关治疗性癌症疫苗的文献进行了首次全球文献计量学分析,旨在探索研究现状和潜在研究趋势.研究结果表明，出版物数量和引用数量均呈持续上升趋势。美国成为发表论文数量最多的主要贡献者。此外,对参考文献和关键词的分析表明，治疗性癌症疫苗长期以来一直是热门话题，而新抗原疫苗，mRNA疫苗，组合战略，和疫苗输送系统是新兴的研究热点。本文献计量学研究对2013年至2022年治疗性癌症疫苗的现有知识和潜在发展进行了全面而重要的概述，为有兴趣进一步探索这一前景广阔的领域的学者提供有价值的参考。
